Williams-Sonoma Likely To Report Higher Q1 Earnings; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
Williams-Sonoma Likely To Report Higher Q1 Earnings; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
Williams-Sonoma, Inc. (NYSE:WSM) is set to release earnings results for its first quarter, before the opening bell on May 22.
威廉姆斯-索諾瑪公司（紐約證券交易所代碼：WSM）將在5月22日開盤前公佈其第一季度業績。
Analysts expect the San Francisco, California-based company to report quarterly earnings at $2.68 per share, up from $2.64 per share in the year-ago period. Williams-Sonoma is projected to report quarterly revenue of $1.65 billion, according to data from Benzinga Pro.
分析師預計，這家總部位於加利福尼亞州舊金山的公司將公佈的季度收益爲每股2.68美元，高於去年同期的每股2.64美元。根據Benzinga Pro的數據，威廉姆斯-索諾瑪預計將公佈16.5億美元的季度收入。
On March 13, Williams-Sonoma posted better-than-expected earnings for its fourth quarter. The company announced a new $1 billion stock repurchase authorization and increased its quarterly dividend.
3月13日，威廉姆斯-索諾瑪公佈的第四季度收益好於預期。該公司宣佈了新的10億美元股票回購授權，並增加了季度股息。
Williams-Sonoma shares fell 0.7% to close at $314.38 on Tuesday.
週二，威廉姆斯-索諾瑪股價下跌0.7％，收於314.38美元。
Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Benzinga的讀者可以在分析師股票評級頁面上訪問最新的分析師評級。讀者可以按股票行情、公司名稱、分析公司、評級變化或其他變量進行排序。
Let's have a look at how Benzinga's most-accurate analysts have rated the company in the recent period.
讓我們來看看Benzinga最準確的分析師在最近一段時間對該公司的評級。
- Wedbush analyst Seth Basham maintained an Outperform rating and raised the price target from $330 to $350 on May 17. This analyst has an accuracy rate of 72%.
- Evercore ISI Group analyst Oliver Wintermantel maintained an In-Line rating and increased the price target from $310 to $315 on May 14. This analyst has an accuracy rate of 73%.
- JP Morgan analyst Christopher Horvers upgraded the stock from Underweight to Neutral and boosted the price target from $245 to $275 on May 3. This analyst has an accuracy rate of 72%.
- Telsey Advisory Group analyst Joseph Feldman maintained an Outperform rating and boosted the price target from $320 to $340 on March 25. This analyst has an accuracy rate of 73%.
- Barclays analyst Adrienne Yih maintained an Underweight rating and raised the price target from $146 to $232 on March 15. This analyst has an accuracy rate of 69%.
- Wedbush分析師塞思·巴沙姆維持跑贏大盤的評級，並於5月17日將目標股價從330美元上調至350美元。這位分析師的準確率爲72％。
- Evercore ISI集團分析師奧利弗·溫特曼特爾維持在線評級，並於5月14日將目標股價從310美元上調至315美元。這位分析師的準確率爲73％。
- 摩根大通分析師克里斯托弗·霍弗斯於5月3日將該股從減持上調至中性，並將目標股價從245美元上調至275美元。這位分析師的準確率爲72％。
- 泰爾西諮詢集團分析師約瑟夫·費爾德曼維持跑贏大盤的評級，並於3月25日將目標股價從320美元上調至340美元。這位分析師的準確率爲73％。
- 巴克萊分析師葉艾德麗安維持減持評級，並於3月15日將目標股價從146美元上調至232美元。該分析師的準確率爲69％。
Read This Next: Jim Cramer Calls This Healthcare Stock A 'Worthy Spec,' Recommends Avoiding Canada Goose
接下來閱讀這篇文章：吉姆·克萊默稱這隻醫療保健股爲 “值得關注的規格”，建議避開 Canada Goose
譯文內容由第三人軟體翻譯。